GRANDFIELD & DODD, LLC Nektar Therapeutics Transaction History

GRANDFIELD & DODD, LLC portfolio value:

$80,000
portfolio value

GRANDFIELD & DODD, LLC quarter portfolio value change:

-15.79%
quarter

Nektar Therapeutics 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -25.88% -8.74K shares -50K $3.2 25.06K
Q2 2022 share Decrease -23.06% -10.13K shares -110K $3.8 33.81K
Q1 2022 share Increase +8.25% 3.35K shares -310K $5.39 43.94K
Q4 2021 share Increase +35.66% 10.67K shares 10K $14 40.59K
Q3 2021 share Increase +6.65% 1.86K shares 60K $17.96 29.92K
Q2 2021 share Increase +3.12% 850 shares -60K $17.16 28.05K
Q1 2021 share Increase +8.80% 2.2K shares 110K $20 27.20K
Q4 2020 share Increase +9.02% 2.07K shares 50K $17 25.00K
Q3 2020 share Increase +2.24% 503 shares -140K $16.59 22.93K
Q2 2020 share Increase +19.43% 3.65K shares 185K $23.16 22.43K
Q1 2020 share Increase +19.50% 3.06K shares -4K $17.85 18.78K
Q4 2019 share Increase 0.00% 15.72K shares 339K $21.59 15.72K